Hoeper, Marius M <br/><br/>
Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study.  [electronic resource] 

 -  Circulation  Mar 2013 
 - 1128-38 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1524-4539 
<br/><br/><label>Standard No.: </label>10.1161/CIRCULATIONAHA.112.000765  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Benzamides<br/>Double-Blind Method<br/>Exercise Tolerance--drug effects<br/>Familial Primary Pulmonary Hypertension<br/>Female<br/>Hematoma, Subdural--chemically induced<br/>Humans<br/>Hypertension, Pulmonary--drug therapy<br/>Imatinib Mesylate<br/>Male<br/>Middle Aged<br/>Piperazines--administration & dosage<br/>Protein Kinase Inhibitors--administration & dosage<br/>Pyrimidines--administration & dosage<br/>Young Adult